Home » J&J Pulls Zeftera From Canada Amid Trial Conduct Questions
J&J Pulls Zeftera From Canada Amid Trial Conduct Questions
April 14, 2010
Janssen-Ortho, a Johnson & Johnson (J&J) company, is halting Canadian sales of Zeftera, its skin-infection treatment, after the FDA and the EU
expressed concerns about the sponsor’s conduct of clinical trials.